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Biochemical and Physiological Effects of
Chiordimeform
by F. Matsumura* and R. W. Beeman*
Chlordimeform is a relatively new acaricide/insecticide, whose mode ofaction we have
investigated. It appears to interfere with amine-mediated control of nervous and en-
docrine systems in a variety of ways. Specifically, chlordimeform causes a build-up of the
amines 5-hydroxytryptamine and to a lesser extent norepinephrine in the rat brain in vivo,
antagonizes the in vivo action ofreserpine in the rat (reserpine depletes amine stores in the
CNS), inhibits monoamine oxidase from rat liverin vitro, and causes hypotension in rabbits.
In the American cockroach it directly stimulates the heartin situ, acts synergistically with
tryptamine in vivo, inhibits amine-N-acetyltransferase from cockroach head in vitro, causes
accumulation ofindolamines in cockroaches in vivo, and blocks the stimulation of adenyl-
ate cyclase by octopamine in the cockroach CNS in situ. It also inhibits tryptamine metabol-
ism in whole mites in vitro.
Chlordimeform is a very unusual pesticide from
several standpoints. First, its effectiveness against
insect and acarine pests in the field does not always
come from its direct killing action. For instance,
chlordimeform causes marked excitation in adult
rice stem borers which results in abnormal egg-lay-
ing behavior. In the young larvae, chlordimeform
causes different types of behavioral changes which
may be collectively described as general sedation.
Here the larvae are inactive and therefore do not
find proper sites for boring. Affected larvae often
do not drill holes into the stem, and, even if they
enter the stem, seldom eat. Chlordimeform also has
some repellent action, and hence some larvae have
been observed to move away from the normal food
source. Second, chlordimeform exhibits a remarka-
ble selectivity to a few groups of arthropods,
namely to lepidopterous insects and acarine
species. Even within the lepidopterous insects its
effectiveness is often confined to mature eggs,
young larvae, and in limited instances to adults.
Such a selectivity pattern has never been observed
in other classes of insecticides-acaricides. Third,
chlordimeform pauses very different symptoms in
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different animal species and stages. In addition to
the above example of the rice stem borer, where
adults show an entirely different poisoning
symptom from the larvae, we know that the
symptoms elicited by one mammalian species can
differ from those shown by another species. Cows
which are treated with chlordimeform for cattle
tick control are known to show marked sedation,
while chlordimeform-treated dogs exhibit
symptoms of excitation.
Fourth, chlordimeform is effective against many
types ofmites and insects resistant to conventional
pesticides, such as organophosphates and chlori-
nated hydrocarbon insecticides (1). This should
mean that the defense mechanisms acquired by
these resistant populations are useless against
chlordimeform, indicating that it is likely to have
an entirely different action mechanism from those
conventional pesticides.
From the above description it must be apparent
thatour interest in chlordimeform has grown out of
our suspicion that its action mechanism was new.
This possibility of a novel poisoning mechanism
suggests new areas ofresearch involving studies on
hitherto unsuspected weaknesses of these pest
species as well as its biochemical and physiological
effects on mammalian species.
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Studies in Higher Animals
Acute Toxicity andPoisoningSymptoms: The
acute toxicity of chlordimeform to mammals is
relatively low. By our estimation the acute, in-
traperitoneal LD50 values for rats is 200 mg/kg.
Acute oral and intraperitoneal LDso values for
mice and rabbits are also estimated to be of the
same order of magnitude (CIBA information
sheet).
At a high dose (200 mg/kg, IP) chlordimeform
causes marked hyperexcitation in a short time
period (5 to 10 min) in rats and mice. They exhibit
tremors and become extremely hypersensitive to
external stimuli. The poisoned animals show signs
oflocomotive difficulties, partly dueto frequent hy-
perextension of hind legs. It is important to note
herethatthe death, ifit is going to occur, almost al-
waystakes place inthisperiod ofhyperexcitation at
a very early stage (1-3 hr). In other words, the
animals which can withstand this eventually
recover. In rats at all doses tested (50-200 mg/kg),
gradual dilation of pupils took place over a 1-hr
period. Throughoutthe entire duration ofthis early
excitation period the animals have not been ob-
served to show cholinomimetic symptoms as slow-
ing of the heart beat, salivation, urination or
fasciculation.
Following these initial periods of hyperexcita-
tion the animals gradually fall into a state of seda-
tion. The transition can be clearly recognized, since
they no longer make attempts to run around. Atthe
midst of the sedation period, the poisoned rats,
when placed in an open area, no longer show the
escape reaction to a nearby corner, or a shelter. In-
stead, they stay motionless in a characteristic low
posture unless they are externally stimulated. The
state of sedation induced by chlordimeform differs
from the one induced by general sedatives such as
phenobarbital, in that in the former case the
animal remains alert to external stimuli such as
clapping ofhands, showing quickjumping and run-
ning responses.
At lower doses (50-200 mg/kg) the duration of
the initial excitation period becomesshorter, and in
some instances the animal shows no sign ofexcita-
tion. In such animals intermittent periods of"seda-
tion" occur over a 1-hr period.
The recovery occurs gradually and in most cases,
the animals behave seemingly normal within 24 hr.
Physiological and Biochemical Effects in Vivo:
An interaperitoneal injection of200 mg/kg ofchlor-
dimeform into rabbits caused a marked decrease in
mean arterial pressure (carotid artery) of almost
50% within 30 min of injection (Fig. 1). To study
the change in amine levels male rats were first tre-
ated with 200 mg/kg (IP) of chlordimeform, were
killed after 1 hr, and their brains quickly removed.
The serotonin and norepinephrine levels in the
whole brain were then measured by the method of
Maickel et al. (2). The result, shown in Table 1, in-
dicates that the amine levels, particularly that of
serotonin, were noticeably high in the brains of
chlordimeform treated rats.
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FIGURE 1. Effect of chlordimeform on the mean arterial
pressure ofthe anesthetized rabbit. Male rabbits weight-
ing 1.4-4.5 kg were anesthetized with 1 mg pentathol, IV,
and anesthesia was maintained with nembutal. The
carotid artery was cannulated, and the mean arterial
pressure was monitored continuously. Saline or chlor-
dimeform hydrochloride (200 mg/kg, 50 mg/ml) was in-
jected IP at the time indicated by the arrow.
Table 1. Serotonin and norepinephrine levels in whole rat
brain a
Chlordimeform Control
Serotonin, jtg/g wet weight 0.75 ± 0.07 0.44 ± 0.06
Norepinephrine, Ag/g wet
weight 0.22 ± 0.01 0.18 ± 0.03
aData expressed as levels ± standard deviation. Averages of
six animals each for serotonin and three animnals each for
norepinephrine. Data uncorrected for extraction efficiencies.
Male 150 g rats were used. Animals were injected in-
traperitoneally (IP) with 200 mg/kg of chlordimeform (hy-
drochloride salt) in aqueoussolution, injection volume = 0.7 ml.
Control rats received 0.7 ml 130. Animals were sacrificed 1 hr
after injection.
Biochemical Effects in Vitro: It has been
already reported that chlordimeform does not in-
hibit cholinesterase (1). Thus, we had to look
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system of chlordimeform.
To study the biochemical cause of chlor-
dimeform poisoning, we have examined its effect
upon the monoamine oxidase ofthe rat liver. Livers
were homogenized in 5 volumes of cold distilled
water. The homogenate was filtered through glass
wool and used directly as the enzyme source.
Enzyme and inhibitors were preincubated for 15
min at room temperature. Enzyme activity was
defined as the amount of kynuramine metabolized
in 20 min at 37°C.
The results (Table 2) indicate that chlor-
dimeform is an inhibitor of monoamine oxidase
(MAO). Also, the degrees of inhibitory potency of
the chlordimeform analogs correlate roughly with
those of the general in vivo toxicity of these com-
pounds to mites.
To study the effect of chlordimeform on a
cholinergic receptor, the isolated frog rectus ab-
dominis preparation was used. Male frogs (Rana
pipiens) were pithed, and the pair of rectus ab-
dominis muscles were dissected out. The posterior
tendon (origin) of the muscle was anchored to a
glass rod, and the insertion (anterior) was tied to
the writing arm of a smoke drum recorder. Test
compounds were dissolved in eserinized frog
Ringer's. The preparation was immersed in the ap-
propriate experimental solution, and muscle con-
tractions were recorded as changes in length by dis-
placement ofthe writing arm on the rotating drum.
It was found that 10-3M chlordimeform had no
effect on an eserinized muscle which was sensitive
to 7 x 10-7M ACh (Fig. 2). Thus, chlordimeform
poisoning is not mediated bycholinergic systems as
far as its excitatory aspects are concerned.
In Vivo Antagonism by Reserpine: We have
observed that chlordimeform acts as a reserpine
antagonist in the rat, for certain symptoms. Reser-
pine at a dose of 10 mg/kg, IP, causes immobility,
tremor, and muscle rigidity in the animal. These
symptoms appear within 45 min of injection, and
last at least 30 hr. Rats which were pretreated with
chlordimeform (50 mg/kg, IP) 90 min prior to
reserpine administration did not develop tremor,
and the muscle rigidity was greatly reduced. These
symptoms did not develop in the chlordimeform-
pretreated rats, even after 10 hr ofreserpinization.
To demonstrate the antagonistic action of chlor-
dimeform on prereserpinized rats, we injected
chlordimeform (50 mg/kg) into rats 2 hr or 30 hr
after reserpinization (10 mg/kg). In both cases,
chlordimeform treatment was followed within 10
min by the complete disappearance of tremor and
rigidity ofthe muscles. Such an antagonistic action
of chlordimeform could be explained by a possible
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Table 2. MAO inhibition bychlordimeform analogs and by
known MAO inhibitors.'
Structure Name pI5b
I \ CH2-CH2-NH-NH2 Phenelzine 5.46 ± 0.14
0 ,,.-CH3
C-NH-NH-CH Iproniazid 3.5() ± 0.08
-CH3
ci N=CH-N' Chlordimeform 4.49 + 0.05
CH3
CH3
/I \ N=CH-NH-CH3 C-8520 4.60( ± 0.05
CH3
,CH3
3 N- NCH-N :3.85 ±! 0.0:3
- 3 CH3
CH3
ci / \N-CH-N C-4789 :3.81 ± 0.07
CH3
/CH3 / \3 N=CH-N :3.23 ± 0.01
CH3
'Inhibitors were added to reaction tubes in 20,ul solvent
(H20 or 95% ethanol). Control tubes received solvent alone.
Preincubation was begun by addition of enzyme (0.1 ml of
filtered liver homogenate). The reaction was initiated by addi-
tion of 0.3 Amole of the substrate kynuramine dihydrobromide
in 20M' of H20.
bData expressed as pl5o ± standard deviation, where pLo =
± log Io, Iso being inhibitor concentration in mole/l. (final con-
centration) giving 50% inhibition. Each value is mean of three
to five determinations.
central adrenomimetic activity, since tremor and
muscle rigidity in reserpine treated rats has been
associated with low levels ofdopamine in the brain
(3).
Studies in Arthropod Species
Chlordimeform has varied effects in various
arthropod species, and it is not easy to come up
with a typical representative study material. For
instance, despitethe effectiveness ofchlordimeform
against mite species, particularly mite eggs, little
work has been done on the physiology of mites
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ACETYLCHOUNE
FIGURE 2. Muscle contractions of frog (Rana pipiens) rectus
abdominus in response to chlordimeform (10-3M) or
AChBr (7 x 10-7M). The muscle origin was anchored to a
glass rod, and the insertion was tied to the writing arm of
a smoke drum recorder. Solutions were prepared by dis-
solving chlordimeform hydrochloride or acetylcholine
bromide in eserinized frog Ringer's (0.002% eserine sul-
fate). Eserinization sensitized the muscle to ACh and
prevented accommodation to repeated doses of ACh.
because of their prohibitively small size. Lepidop-
terous larvae are large enough, but generally un-
suited for electrophysiological studies.
With respect to amine-related systems, our cur-
rent knowledge in arthropod species is meager at
best (4).
In the insect nervous system so far, biogenic
amines, including the catecholamines
norepinephrine and dopamine, and the indolamine
5-hydroxytryptamine (serotonin), have been
detected, and their pharmacology has been in-
vestigated. MAO activities have been detected in
cockroaches (5), grain beetles (6), European corn
borers (7) and blowflies (8), but no one has yet
shown the possible functional meaning of its pre-
sence.
In view ofthe limitations in the basic knowledge
on these biochemical systems in most arthropod
species, we have decided that cockroaches are the
best initial study material, despite their general in-
sensitivity to chlordimeform. Cockroaches, par-
ticularly American cockroaches, have been exten-
sively used by physiologists and biochemists. They
are most suited for electrophysiological studies.
Not onlythat, butthe American cockroach is one of
two species* that has been shown to have a
biogenic amine (serotonin) in the central nervous
system (10-12). A basic similarity in insect and
mammalian amine regulatory mechanisms can be
inferred from the effects of reserpine or a MAO in-
hibitor on the levels of biogenic amine in the
cockroach brain (13,14).
*Catecholamines have been also detected in the brain of a
locust species (9).
General Observations In the American Cock-
roach: Intraabdominal injection of chlor-
dimeform hydrochloride gave an LD50 of about 500
,ug/g of body weight for American cockroaches. In-
jection of LD50 is followed within 5 min by typical
symptoms of intoxication. Symptoms include un-
coordination, hyperactivity, arching, and wing flap-
ping. Prostration becomes irreversible over a
period of several hours, and paralysis begins in
10-20 hr. Chlordimeform did not cause tremor or
twitching, and seldom induced convulsions, even at
a high dose (670 Aglg). A sublethal dose of chlor-
dimeform (420 ,g/g) was followed by symptoms
which lasted at least 6 hr before the insects
recovered.
For comparative purposes, American
cockroaches were poisoned with a standard MAO
inhibitor, tranylcypromine hydrochloride, and the
symptoms were observed. Tranylcypromine gave
an LD50 of about 700 Ag/g and caused hyperac-
tivity, uncoordination, arching, and wing flapping
within 5 min of injection ofthe LD50 dose. In addi-
tion to the chlordimeform like syndrome, there is
another set of symptoms, including body convul-
sions and tremor and twitching ofthe appendages,
which are absent in chlordimeform-poisoned in-
sects. The usual sequence of symptoms in tra-
nylcypromine-poisoned insects is uncoordination,
hyperactivity, arching and wing flapping, soon
followed by convulsions and prostration. Twitch-
ing of legs is characteristic ofthe prostrate insects,
followed by tremor, and finally paralysis.
Preliminary experiments have established that
chlordimeform does not inhibit housefly head
cholinesterase even at 10 -3M, nor did it affect the
(Na-K) ATPase of the roach head at this con-
centration.
From our symptomatological observations we
suspected CNS involvement in chlordimeform
poisoning in American cockroaches.
Electrophysiological Studies in the American
Cockroach: The effects of chlordimeform on the
Aectrical activity of the exposed cockroach ventral
nerve cord were studied. Within 10-20 min after
flooding the exposed nerve with 10-1M chlor-
dimeform hydrochloride solution, the first
electrophysiological evidence of damage to the
CNS becomes apparent. This always consists of
shortvolleys ofaction potentials, usually about 100
,uV in amplitude. The frequency of action poten-
tials within the volley is roughly 4/10 msec,
decreasing slightly toward the end of each volley.
The volleys, which usually consist of4-7 action po-
tentials, occur irregularly at a frequency of about
2-4/sec. The duration ofeachvolley is on the order
of 15 msec.
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74Table 3. Inhibition of tryptamine metabolism from combined cockroach heads and ventral nerve cords.
Compound Structure so ± SD'
/\ ~~CH3
Chlordimeform Cl N=CH-N 4.4:3x 10-±0.41
- 3 CH3
CH3
Desmethylchlordimeform Cl / \ N=CH-NHCH3 1.08x 10-+±0.28
CH3
Tranylcypromine CH-CH-NH2 1.41 x iT- + 1.09
CH2
'Data are expressed as ho ± SD. Where Iso is the inhibitor concentration in mole/I. giving 50%
value is the mean of three to five determinations.
Prolonged exposure (up to 2 hr) to this dose of
chlordimeform results in severe hypersensitivity of
the CNS, as evidenced by long trains of repetitive
discharge, both spontaneous and in response to
mechanical stimulation inthe form ofair puffing of
the cerci. Synaptic blockade did not occur, even
after 2 hr ofexposure to 1O-3 M chlordimeform. At
10-4M no evidence of CNS damage could be
detected.
Inhibition of Tryptamime, DOPA, and
Serotonin Metabolism: Chlordimeform inhibited
metabolism of 14C tryptamine in the cockroach
head, as shown in Table 3. Ofthe three compounds
tested, tranylcypromine, a known inhibitor of
mammalian MAO, was the most potent inhibitor.
In view ofthe absence of detailed studies on insect
MAO, an assumption was made here that tryp-
tamine is degraded by MAO. Recent work (15; un-
published observations from this laboratory) has
shown that N-acetylation rather than oxidative
deamination is the predominant pathway for tryp-
tamine in the roach brain. To shown that such an
inhibition of tryptamine metabolism by chlor-
dimeform has some physiological conisequences in
vivo, the joint actions of chlordimeform and tryp-
tamine were investigated (Table 4). The results
clearly indicate that these two chemicals act syn-
ergistically.
In addition, the effect of chlordimeform on the
in vivo metabolism of externally applied 3H-L-
DOPA (a catecholamine precursor) was studied in
male cockroaches. The results (Table 5) show that
norepinephrine accumulates in poisoned insects to
inhibition ofenzyme activity. Each
Table 4. Potentiation of chlordimeform toxicity by
tryptamine.
Mortality, %
Chlordimeform Acetone Chlordimeform
+ + +
H2O tryptamine tryptamine
Trial 1 10 0 70
Trial 2 20 0 80
aData are expressed as mortality 30 hr after injection of
tryptamine (500 ,ug) or H20. Ten roaches were used for each
combination (total, 60 roaches). Chlordimeform (100Ag/roach)
was given topically with 5 ,ul of acetone.
a greater extent than in unpoisoned ones, in agree-
ment with the observation of Rutschmann et al.
(16) with established MAO inhibitors in the rat
brain.
We have also studied the metabolic fate of 14C-
serotonin as it is affected by chlordimeform. The
results shown in Figure 3 clearly indicate that the
metabolic pattern of serotonin is altered by the
chlordimeform treatment. It must be noted
however, thatthe amount ofserotonin remaining in
the control is not significantly different from that
in the treated animal. It was a qualitative change
in the distribution of metabolites that was signifi-
cant.
Histochemical Investigation in the Roach
Brain: To ascertain that the basic amine
regulatory mechanisms in the central nervous
system of the American cockroach are similar to
those found in mammalian brain, the histochemi-
April 1976 75Table 5. In vivo metabolism of 3H-L-DOPA and accumula-
tion of amines as affected by chlordimeform in the
American cockroach.a
Amounts, % of recovered
radioactivityb
Control Treated
L-DOPA 5.85 11.36
Norepinephrine 11.05 18.36
Dopamine 9.60 8.65
Other metabolites 74.17 61.75
aAfter 24 hr metabolism by male roaches. Roaches were ex-
tracted with 10 volumes of acidified n-butanol and the debris
removed by brief centrifugation. The supernatant solution was
extracted with 1 ml of0.1N HCI, with 15 ml ofn-hexane added
to aid separation. Solvent and aqueous phases were concentr-
ated and spotted on cellulose MN 300 TLC plates along with
nonradioactive reference compounds, and the plates were
developed in methanol-benzene-n-butanol-water (4:4:4:1).
bResults expressed in percentages of applied radioactivity
(0.14 nmole of 3H-L-DOPA, specific activity 15 Ci/mmole)
recovered in each fraction. Average of two determinations.
cChlordimeform given topically at a dose of 100 ,ug/ roach 3
hr prior to the oral administration of 3H-L-DOPA. The total
poisoning time for chlordimeform was 27 hr.
cal experiment of Frontali (13) was repeated. In
this experiment biogenic amines were made visible
by treating the freeze-dried roach brain with for-
maldehyde vapor. The brains were then embedded
and sectioned, and the sections viewed through a
fluorescence microscope. By such an approach it
was possible to show that reserpine had the ex-
pected effects of depleting the amine storage in the
roach brain. On the other hand, any changes in
amine levels brought about by either chlor-
dimeform or tranylcypromine (a typical MAO in-
hibitor) were subtle and were not detectable by
such a crude, qualitative assay method (Fig. 4).
Measurment of Effects of Chlordimeform on
Amine Receptors in the Cockroach CNS and
Heart: To study the effects of chlordimeform on
the CNS receptors for biogenic amines in the
cockroach we adopted the method of Nathanson
and Greengard (17). This method measures
stimulation of adenylate cyclase in the cockroach
central nervous system as a result ofthe addition of
exogenous biogenic amines. The sensitivity of the
assaymethod is 1 pmole/4.5 thoracic ganglia. It im-
mediately became apparent that it was not sensi-
tive enough to measure the increase in the biogenic
amine levels in vivo as a result of either MAOI or
chlordimeform treatment. However, when their
effects were tested in situ (by using isolated half
ganglia) two important phenomena became known
(Table 6). First chlordimeform itself does not
stimulate the adenylate cyclase activity (i.e., it does
FIGURE 3. In vivo metabolism of exogenous serotonin in the
adult male American cockroach. Five cockroaches were
treated topically with 100 ,ug of chlordimeform (free
base) in 5 ,ul acetone. Four additional roaches (controls)
received acetone alone. After 2 hr, both groups were in-
jected with 2.0 j,Ci of 14C-serotonin creatinine sulfate
(16.2 ,ug) in 2,ul H20, and were held for an additional 24
hr. Roaches were then homogenized, each in 2.0 ml of
acidified n-butanol. To account for nonmetabolic break-
down, one roach was homogenized immediately after in-
jection of5-HT. Homogenates were filtered throughglass
wool and centrifuged at 20,000 g for 10 min. A 10,l ali-
quot of each supernatant fraction was spotted on silica
gel HF chromatographic plates, under a constant stream
of N2. Plates were developed in darkness (solvent system
used wasmethanol:benzene:n-butanol:H2O, 4:4:4:1) and
exposed to x-ray film for 3 weeks: (spot 1) nonmetaboliz-
ing control; (spots 2-5) untreated; (spots 6-10) chlor-
dimeform-treated. Major spot at Rf = 0.45 corresponds
to serotonin.
not act as a false transmitter in this preparation),
and second (at 10-3M) it instead prevented ex-
ogenously added octopamine from achieving the
maximum stimulation of adenylate cyclase ac-
tivity. On the other hand, chlordimeform at 10-5M
was found to increase the rate of cockroach heart
beat.
Toxicities of Typical MAO Inhibitors to
Cheese Mites: As mentioned before, a MAO in-
hibitor such as tranylcypromine has been found to
be almost as toxic to the American cockroach as
chlordimeform: the fact itselfmaybe used as a sup-
portive evidence in favor of an amine-related mode
of action of chlordimeform in insects. The
American cockroach is not a really susceptible
Environmental Health Perspectives 76A B
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FIGURE 4. Catecholamine-induced fluorescence in brains ofcockroaches (adults, male Periplaneta americana) receiving one ofthe
following drug treatments: (A) untreated; (B) reserpine (50 Ag); (C) chlordimeform (50 ,ug) plus DOPA (250 ,g); (D) tra-
nylcypromine (100,ug) plusDOPA (250Mg). Drugswere administered on each ofthree consecutive days. On day 4, the brains were
removed, quicklyfrozen at Dry Ice temperature, and freeze-dried. Brains werethen exposed to paraformaldehyde (equilibrated at
50% RH for 1 week) at 80°C for 3 hr, embedded in Paraplastin vacuo, and sectioned at 8 ,um. Sections were mounted in mineral
oil and viewed under fluorescence microscopy. A catecholamine-rich area of the protocerebrum (showing central body and
mushroom body beta-lobes) was photographed by using Kodak high-speed Ektachrome type B film.
species for chlordimeform, however, and as such it
seems appropriate to find whether MAOI are also
effective against chlordimeform-susceptible
species. In Table 7 we have summarized the results
of our preliminary experiments on the toxicity of
MAOI against the cheese mite. It can be seen that
these MAOI can be good acaricides.
Tryptamine Metabolism by Homogenates of
Whole Cheese Mites and Inhibition by MAO
Inhibitors: To study the effect of chlordimeform
on amine metabolism in a susceptible specie, we
used the MAO assay technique of Wurtman and
Axelrod (18) and applied it to whole mite homoge-
nates. Cheese mites (Tyrophagus putrescens) were
homogenized in cold 0.25M sucrose at 75 mg/ml.
The homogenate was centrifuged at 600g for 5 min,
and the supernatant was used directly as the
enzyme source. Assay tubes contained 0.5M
phosphate buffer pH 7.4 (0.4 ml), distilled water
(0.2 ml), and enzyme (0.1 ml). Inhibitors were ad-
ded in 7 1.d of distilled water, and tubes were incu-
bated at room temperature for 15 min. The reac-
tion was initiated by addition of 14C-tryptamine
(0.01 ,uCi, 0.21 nmole) in 10 1,u of 2% EtOH. The
reaction was carried out for 30 min at 37°C, and
terminated by the addition of 0.7 ml of 2N HCl.
April 1976 77Table 6. Effect of chlordimeform on adenylate cyclase
and octopamine-induced stimulation of adenylate
cyclase in roach thoracic gangliain situ.
Treatment 3H-c-AMP bound ± S.D., % b
Control 12.9 ± 0.3
Chlordimeform, I x 10-3M 13.3 ±0.7
Control 15.0 ± 2.6
Octopamine, 2.5 x 10-4M 6.4 ± 1.3
Octopamine, 2.5 x 10-4M + 11.6 ± 0.7
Octopamine, 2.5 x 10-4M + 11.6 ± 0.7
chlordimeform 1 x 10-3M
aIntact hemiganglia (containing adenylate cyclase) were in-
cubated with no treatment, chlordimeform alone, octopamine
alone, or octopamine and chlordimeform together, and ac-
cumulated c-AMP was measured by competitive binding to a
c-AMP binding protein. Procedural details are given in Nathan-
son and Greengard (18).
bData are expressed as % 3H-c-AMP bound ± standard
deviation. All values are means of three to six determinations.
Decreased binding indicates increased cyclase activity.
The toluene-extractable reaction product was
measured by liquid scintillation spectrometry. The
mites were found to be rich in a tryp-
tamine-metabolizing enzyme, with product being
formed at the rate of 6.7 cpm/mg whole mite/min
(uncorrected for counting efficiency). The enzyme
was highly sensitive to chlordimeform and to a
number of MAO inhibitors (Table 8), although
chromatographic analysis of the major product
showed it to be different from 3-indolacetaldehyde,
indole-3-acetic acid, and from N-acetyltryptamine.
Discussion
Mechanisms of Action in Mammals
There is little doubt that chlordimeform at cer-
tain concentrations (Table 2) can inhibit MAO ac-
tivity. However, whether such an inhibitory proper-
ty of chlordimeform by itself can account for its
toxic action should be the center of discussion.
First, a consideration should be given to the fact
that these so called MAOI are seldom found to be
acting as pure MAO inhibitors. For instance, tra-
nylcypromine is known to be a dangerous MAO in-
hibitor, since it also has some amphetamine-like
action which greatly magnifies its MAO-inhibitory
effects. Amphetamine inhibits re-uptake of
catecholamines by specific neurons, in addition to
its direct stimulating effects. Thus, often the causes
of poisoning by so called MAOI are not simple.
Second in studying the action mechanisms of
chlordimeform analogs, we must be also aware of
Table 7. Toxicity of MAO inhibitors to the cheese mite,
Tyrophagusputrescens.a
Compound Dose, Ag/vial Mortality, %
Chlordimeform 1 0
5 100
Tranylcypromine 5 0
20 100
SKF 9355 A 5 0
8 50
13 90
20 100
SKF 9208 A 5 0
8 10
13 80
20 100
Deprenyl 1 0
3 50
5 100
aScrew cap vials, 12 x 24 mm, were treated by evenly coating
the inside surface with 20 ,u of an acetone solution of the com-
pound, followed by evaporation ofthe solvent. Ca. 50 mites (all
stages) were introduced into each vial, and 12 hr mortality was
estimated.
the possibility that small alterations in chemical
structure may produce important changes in
biological activity. For example, it has been shown
that pyridyl formamidines possess adrenergic and
cholinergic blocking action, whereas phenyl and
naphthyl formamidines are cholinomimetics
(19,20). Such consideration is important in examin-
ing the metabolic products of chlordimeform as
possible active agents. With the above conditions in
mind, let us proceed to weigh all the available evi-
dence.
It is generally understood that medically used
MAOI act rather slowly. MAO inhibitors also
generally produce long-lasting, irreversible inhibi-
tion of MAO, so that serial doses tend to be
cumulative. For example, large doses of pargyline
produce a two-phase syndrome in mammals, in-
cluding a fast and slow response (21). There is an
initial depression of motor activity probably due to
direct actions of the drug. The second phase of the
syndrome is a gradual increase in activity and ir-
ritability. These slow effects develop in 4-24 hr
and are probably due to catecholamine and 5-hy-
droxytryptamine accumulation in the central ner-
vous system. The delayed effects of pargyline are
tvpical of MAO inhibitors. In all species of mam-
nmal studied, most deaths from toxic in-
traperitoneal doses ofpargyline were delayed 8-24
hr.
In contrast, the symptoms chlordimeform causes
are almost reversed in time sequence. The
Environmental Health Perspectives 78Table 8. Tryptamine metabolism by whole mite homogenates and inhibition by MAO inhibitors.
Compound Structure 150 ± S.D.a
hlh i-di IIIfo,,i'm (cI N=('H-N 6.85 x 10-"±0.35
-('H3
CH3
IraI l.vIcvItX)roml),C(H /' H-('H-NH2 2.18 x I0-'i± 0.69
-=J ('H2
('I
SKI" 9157-A C' \ H-CH-NH2 6.5: x 10-"+±().64
('H2
(,1
SKF" 97 2-A /' H-('H-NH2 4.62 x 1(±-+0.84
-CH2
SKF 6279-A ('I CH-CH-NH2 1.88 x l(-1±'+0(.96
CH2
(*1
SKF 9:55-A ('I /' H-('H-NH2 '3150 x I(0-'i± 1.24
('H2
('I
SKF 9208-A / ('H-('H-NH2 2.73 x 10-'i+±2.50
('H2
(.I
SKi" 9671-A /'H-('H-N NH-CH3 4.43 x 10'+(±0.43
- (H2
CH3
SKFi 556i-A / CH-C,H-N 3.00 x 10-'+±0.3O
CH2 CH3
CH3O
SKF 1(714 J CH30 CH-CH-NH2 >10"-
CH2
SKF 9769-A /' 1 (('I1NCH-NH-('H1 3.32 x 10'-±0.43
D)epren l ('12.(C'HN-('I`2-(C'-('I 5.80 x IO-"b
H('13 ('11,
/ / (~~~~~~112 i1.ill51641 o.('11.('H2.NH-('/I 2.0)xlO
'Data are expressed as I5o ± S.D., where Iso is the inhibitor concentration in mole/I. giving 50%(- inhibition ofenzmrne activity. Most
values are means of three determinations.
bOne determination.
April 1976 79symptoms of hyperactivity and irritability begin
immediately after injection, and depression of
motor activity sets in much later stages. Death is
associated with the symptoms at the early stage.
Thus, it is clear that chlordimeform does not elicit
a typical MAOI symptom. Rather the early violent
excitation could be caused either by its direct ac-
tion on amine receptors or by a yet unknown
mechanism. Inthe former case, chlordimeform acts
directly as a false transmitter (like amphetamine)
and thereby stimulates the post-synaptic
membrane. If such is the case, its MAO inhibitory
action must play a synergistic role in the course of
chlordimeform poisoning in the same way as tra-
nylcypromine works.
The above hypothesis is consistent with our ob-
servation that poisoned rats always developed
pupillary dilation within 1 hr ofpoisoning, indicat-
ing either direct stimulation of the receptor or
stimulation of the norepinephrine (NE) releasing
mechanism. Tyramine (like amphetamine) also
promotes nonneural leak-out of NE, peripherally
and centrally. MAO inhibitors potenitiatetyramine
action by increasing extragranular NE available
for leak-out (21). The possibility that direct action
of chlordimeform plays a part in its poisoning pro-
cesses has been suggested by us (22).
While the above symptomological observation
suggests that the MAO inhibitory action of chlor-
dimeform alone may not serve as the primary cause
for the early excitation effect (and thereby its "kill-
ing action"), there are indications that such an in-
hibitory property of this pesticide plays a part in
eliciting at least certain symptoms.
It has been noted that chlordimeform causes a
hypotensive effect (i.e.,sustained reduction in mean
arterial pressure in the rabbit). Arterial hypoten-
sion is produced by most MAOI compounds and is
generally ascribed to interference with NE libera-
tion from peripheral sympathetic terminals, to ac-
cumulation of false transmitters such as oc-
topamine and dopamine (bothhave weaker pressor
action than NE), or to central effects such as the
ones produced by a-methyldopa. Thus, this hy-
potensive effect should be regarded as indirect evi-
dence for the MAOI-like behavior of chlor-
dimeform.
The second evidence is that chlordimeform
clearly acts antagonistically to reserpine, which is
known to deplete amines from neurons by promot-
ing leak-out from presynaptic storage sites (23).
Such depletion should make a MAOI less effective
because ofthe lack of amines to accumulate at the
synapses, and because of the reserpine induced
blockade ofthe receptor as a resultofsudden flood-
80
ing of synaptic areas with NE at an early stage of
reserpine poisoning.
In summary, it appears that in the rat the MAO
inhibitory action ofchlordimeform plays a suppor-
tive part in inducingthe earlyexcitation symptoms.
The primary cause of the excitation could come
from its direct action. At later stages of poisoning
such a MAO inhibitory action may become signifi-
cant as judged by its antagonistic action to reser-
pine. Another effect of chlordimeform could be a
blocking action on amine receptors as a result of
severe chlordimeform poisoning, particularly late
stages of poisoning. Such receptor blockade is ex-
pected to cause sedation. In the final analysis it is
entirely possiblethat all these actionstogether con-
stitutethe unique poisoning case ofchlordimeform.
Thus, in studying the mode of action of chlor-
dimeform our emphasis is the "amine-related"
systems and not just MAO inhibition which likely
plays only some part in chlordimeform poisonings.
Last, it is importantto mention herethatthere is
a high degree of variation among animals in the
levels of amines and associated enzyme activities.
For example, pargyline, when administered
chronically to monkeys in large doses (100-150
mg/kg-day) produces only mild restlessness. In
man, however, doses of only 3-4 mg may lead to
dangerous side effects (21). Species differences
could also be enormous for chlordimeform. There
is danger in drawing inferences about human safety
from animal data.
Mechanisms of Action in Insects and
Mites
There are reasons why we separated the section
on insects and mites from that on mammalian
species. First, in arthropod species the functional
roles of biogenic amines are not well defined, in
contrast to the well studied cases in mammalian
species. Second, chlordimeform acts differently in
different insect, mite, and tick species. Even within
one speciesthe responses elicited by chlordimeform
vary from one developmental stage to another.
Third, inthese arthropod species, "mode ofaction"
is not synonymous with "mode of killing," for in
many cases chlordimeform does not owe its effec-
tiveness to direct killing action. The pests may die
from exhaustion due to induced hyperexcitation
(e.g., silkworm moths), drowning (e.g., rice stem
borer moth), starvation (many lepidopterous lar-
vae) due to its repellent action, loss of appetite, or
behavioral changes. But these are indirect killing
actions, and the truemode ofaction mustbe sought
in nonlethal biochemical changes. At high doses
Environmental Health Perspectivesone can indeed induce killing, but at such con-
centrations many biochemical systems, other than
the true target system, will be affected.
In view of such a background we must stress
here that until we know much more about the un-
derlying principles we should treat each case of
poisoning separately. Even within one species, the
stage of development and the tissue or systems
(such as central nervous system, malpighean
tubules, respiratory system, etc.) must be carefully
specified. This is particularly important, when
dealing with biogenic amine-related events, in-
asmuch as the physiological function of such
systems might differ among the various insect and
mite species or even among the various develop-
mental stages within one species. Such evolution-
ary diversities are not really new. For example,
glutamic acid is a CNS neurotransmitter in mam-
mals, whereas it is a neuromuscular transmitter in
insects.
In cockroaches we first of all have made efforts
to study several biochemical systems that are
known to be affected by conventional insecticides.
A DDT or cyclodienelike mode of action for chlor-
dimeform was ruled out because the pesticide had
no effects on nerve ATPases, and because
electrophysiological symptoms in poisoned nerve
cords were not reminiscent of chlorinated hy-
drocarbonlike actions. Cholinesterase inhibition
was ruled out by the difference in symptoms from
organophosphate poisoning, and by the insen-
sitivity of housefly head ChE to chlordimeform.
The possibility of nicotinelike action (i.e.,direct at-
tack on the receptor as a false transmitter) could
not be adequately checked in the cockroach.
However, a standard preparation ofthe frog rectus
abdominis muscle failed to demonstrate such an
action of chlordimeform. In the past, all insectici-
dal nicotinomimics have been tested by the same
procedure (e.g., nereistoxin, Padan, etc.) and have
been shown to have positive effects.
The respiratory system of the cockroach was
definitely affected by chlordimeform as judged by
the sharp increase in the rate ofrespiration (24,25)
in vivo. A rotenone-type inhibition of coenzyme Q
activity was ruled out bythe lack ofchlordimeform
action on glutamic dehydrogenase activity in the
roach (26). Its uncoupling action on oxidative
phosphorylation was reported (24) and doubtlessly
serves asthe cause ofthe above respiratorychanges
in the roach. However, symptoms of poisoning in
cockroaches are completely different from those in-
duced by DNP, a potent uncoupler of oxidative
phospnorylation. These authors themselves state
that chlordimeform-induced symptoms indicate
"extensive involvement of the nervous system in
poisoning" which cannot be explained by uncoup-
ling.
As for the reports on the properties of blocking
action ofchlordimeform in the frog neuromuscular
junction (27, 28), we believe that at least in the
cockroach such an action does not play a signifi-
cant role. We exposed the isolated nerve cord ofthe
cockroach to 10-3M chlordimeform and observed
that synaptic blockade did not occur, even after 1
hr of exposure, although excitatory neurotoxic
symptoms appeared after only 10 min. (26).
Thus, all of these conventional target systems
being eliminated from the list, we should now
carefully examine the possibility of amine-related
systems being the actual target of chlordimeform.
The mention of "amine-related" systems is impor-
tant, since MAO inhibition may play only a part in
the total picture ofchlordimeform poisoning as dis-
cussed for the mammalian cases. Even well
established MAO inhibitors seldom act as pure
MAO inhibitors, and, furthermore, in arthropod
species the role and in some cases even the presence
of MAO is in doubt. For example, we could not so
far demonstrate the presence ofMAO in theventral
nerve cord of the American cockroach (25).
So far the direct pieces of evidence supporting
the "amine-theory" in cockroaches are: (a) chlor-
dimeform inhibits metabolism of "4C-tryptamine in
the roach head homogenate in vitro at I50 of 4.4 x
10-4M; (b) the killing action of chlordimeform is
potentiated by tryptamine, which by itself is non-
toxic to the roaches; (c) increase in indolamines
levels are observed in the whole body after applica-
tion ofchlordimeform in vivo, and changes occur in
metabolic patterns of serotonin in vivo; (d) chlor-
dimeform at 10-3M (we have not tested lower con-
centrations) blocks the stimulatory action of oc-
topamine on adenyl cyclase in the roach thoracic
ganglion; (e) chlordimeform increases the heart-
beat rate in isolated roach heart preparations, the
phenomenon being compatible with the report that
the cockroach heart is innervated by monoamine-
containing axons (29).
Indirect evidences are that tranylcypromine, a
typical MAO inhibitor, produces very similar
symptoms in the American cockroach. Also, several
MAO inhibitors are good acaricides against the
cheese mite, Tyrophagus putrescens.
On the other hand, there are several unanswered
problems. For example; we have so far been unable
to detect an increase in amine levels in vivo in the
central nervous system of the cockroach. Also, it
has recently been shown that tryptamine is not
metabolized by oxidative deamination in the roach
April 1976 81brain, but rather by N-acetylation (15). In view of
the antagonistic action of mixed-function oxidase
inhibitors (such as sesamex and piperonyl butox-
ide), there is a possibility that one of the metabolic
products, rather than chlordimeform itself, is an
active agent, at least in certain species.
These questions, however, do not directly
challenge the working hypothesis that the toxicity
of chlordimeform in vivo is related to the changes
in biogenic amine levels in quantity and/or in
quality.
In conclusion, we have shown that chlor-
dimeform can indeed affect amine regulatory
mechanisms and in some instances, can react with
certain amine receptors. On that basis we have pro-
posed a working hypothesis that chlordimeform
acts upon amine-related systems. Certainly much
more information is needed to confirm or deny such
a hypothesis. In the future, chlordimeform and its
metabolic products should betested for their effects
on amine re-uptake, leak-out from the presynaptic
storage, metabolism (notjust MAO but many other
enzymes systems) and the range of its action on
amine receptors either as agonist or antagonist.
The key to the safe use of any new pesticide is to
provide the basic toxicological data based upon
logical explanation of its action mechanism and its
side effects. Chlordimeform and its analogs and
metabolites possess very peculiar and unfamiliar
properties, particularly as pesticides. It appears
very important to make efforts at this stage to un-
derstand the basic mechanisms of their actions.
Hopefully our initial efforts are providing the
means to meet the challenge.
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